| Literature DB >> 34682295 |
Li Liu1, Jiri Veis2,3, Wolfgang Reiter2,4, Edwin Motari1, Catherine E Costello5, John C Samuelson1,6, Gustav Ammerer2, David E Levin1,6.
Abstract
The cell wall integrity (CWI) signaling pathway is best known for its roles in cell wall biogenesis. However, it is also thought to participate in the response to genotoxic stress. The stress-activated protein kinase Mpk1 (Slt2, is activated by DNA damaging agents through an intracellular mechanism that does not involve the activation of upstream components of the CWI pathway. Additional observations suggest that protein kinase C (Pkc1), the top kinase in the CWI signaling cascade, also has a role in the response to genotoxic stress that is independent of its recognized function in the activation of Mpk1. Pkc1 undergoes hyper-phosphorylation specifically in response to genotoxic stress; we have found that this requires the DNA damage checkpoint kinases Mec1 (Mitosis Entry Checkpoint) and Tel1 (TELomere maintenance), but not their effector kinases. We demonstrate that the casein kinase 1 (CK1) ortholog, Hrr25 (HO and Radiation Repair), previously implicated in the DNA damage transcriptional response, associates with Pkc1 under conditions of genotoxic stress. We also found that the induced association of Hrr25 with Pkc1 requires Mec1 and Tel1, and that Hrr25 catalytic activity is required for Pkc1-hyperphosphorylation, thereby delineating a pathway from the checkpoint kinases to Pkc1. We used SILAC mass spectrometry to identify three residues within Pkc1 the phosphorylation of which was stimulated by genotoxic stress. We mutated these residues as well as a collection of 13 phosphorylation sites within the regulatory domain of Pkc1 that fit the consensus for CK1 sites. Mutation of the 13 Pkc1 phosphorylation sites blocked hyper-phosphorylation and diminished RNR3 (RiboNucleotide Reductase) basal expression and induction by genotoxic stress, suggesting that Pkc1 plays a role in the DNA damage transcriptional response.Entities:
Keywords: Hrr25; Mec1; Pkc1; Tel1; UV irradiation; hydroxyurea
Year: 2021 PMID: 34682295 PMCID: PMC8541566 DOI: 10.3390/jof7100874
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Yeast strains used in this study.
| Strain | Relevant Genotype | Source or Reference |
|---|---|---|
| DL100 | [ | |
| DL376 | David Levin | |
| DL1021 | Gerhard Paravicini | |
| DL2772 | Research Genetics | |
| DL3950 | Marcus Smolka | |
| DL3951 | Marcus Smolka | |
| DL3952 | Marcus Smolka | |
| DL3953 | Marcus Smolka | |
| DL3954 | Marcus Smolka | |
| DL4206 | Juan Carlos Igual | |
| DL4277 | This study | |
| DL4286 | Research Genetics | |
| DL4290 | [ | |
| DL4503 | This study | |
| DL4515 | This study | |
| DL4527 | This study | |
| DL4528 | This study | |
| DL4541 | This study | |
| DL4542 | This study | |
| DL4555 | This study | |
| DL4556 | This study | |
| JV826 | This study |
Plasmids used in this study.
| Plasmid | Description | Source or Reference |
|---|---|---|
| p117 | pRS313 | [ |
| p118 | pRS314 | [ |
| p119 | pRS315 | [ |
| p120 | YEp351 | [ |
| p813 | YEp351- | David Levin |
| p1105 | pRS425 | [ |
| p1202 | pRS425- | David Levin |
| p2062 | pVDG7 | [ |
| p2454 | pRS413 | [ |
| p2947 | p | Stephen Elledge |
| p3064 | pAG32- | [ |
| p3149 | pRS425- | [ |
| p3357 | pUG36- | Martha Cyert |
| p3358 | pUG36- | Martha Cyert |
| p3484 | pRS425- | This study |
| p3504 | pRS313- | This study |
| p3517 | YEp351- | This study |
| p3521 | YEp351- | This study |
| p3522 | YEp351- | This study |
| p3523 | YEp351- | This study |
| p3525 | pRS315- | This study |
| p3538 | pRS425- | This study |
| p3544 | pRS423- | This study |
| p3545 | pRS313- | This study |
| p3546 | pRS313- | This study |
| p3547 | pRS423- | This study |
| p3550 | pRS313- | This study |
| p3552 | pRS423- | This study |
| p3553 | pRS423- | This study |
| p3560 | pRS423- | This study |
| p3562 | pRS423- | This study |
| p3567 | pRS423- | This study |
| p3570 | pRS313- | This study |
| p3572 | pRS313- | This study |
| p3574 | YEp351- | This study |
| p3576 | pRS313- | This study |
| p3597 | YEp351- | This study |
| p3603 | YEp351- | This study |
| p3604 | YEp351- | This study |
| p3605 | YEp351- | This study |
| p3606 | YEp351- | This study |
| p3608 | YEp351- | This study |
| p3610 | YEp351- | This study |
| p3612 | YEp351- | This study |
| p3617 | YEp351- | This study |
| p3618 | YEp351- | This study |
| p3619 | YEp351- | This study |
| p3623 | pRS314- | This study |
| p3624 | pRS314- | This study |
| p3625 | pRS314- | This study |
| pWR268 | pFA6a-integrative | [ |
Figure 1A phosphorylation band-shift in Pkc1 requires the MEC1 and TEL1 DNA damage checkpoint genes. (a) A Pkc1 band-shift is induced specifically by genotoxic stressors. Wild-type cells (DL3950; sml1Δ) expressing Pkc1-HA (from p813) were exposed to genotoxic stress (250 mM HU for 4 h, 0.04% MMS for 2 h, or 150 J/m2 UV with a 2 h recovery period), cell wall stress (40 µg/mL CFW for 1 h, or heat shock at 39 °C for 1 h), or untreated (Con). Extracts were subjected to SDS-PAGE and immunoblot analysis for Pkc1-HA; (b) Phosphorylation is responsible for the HU-induced band-shift. Wild-type cells (DL3950) expressing Pkc1-HA were either treated with HU as above, or untreated. Extracts were treated with Lambda protein phosphatase (LPP), as described in Methods, prior to immunoblot analysis; (c,d) The HU-induced Pkc1 band-shift requires MEC1 and TEL1, but not the checkpoint genes that they regulate (RAD53 or CHK1). Cultures were treated with HU as above prior to immunoblot analysis for Pkc1-HA. Strains are DL3950 (sml1Δ), DL3951 (sml1Δ tel1Δ), DL3952 (sml1Δ mec1Δ), DL4277 (sml1Δ mec1Δ tel1Δ), DL3953 (sml1Δ rad53Δ), DL2772 (Res. Gen. WT), and DL4286 (Res. Gen. chk1Δ). The sml1Δ mutation is required to suppress the lethality of the mec1Δ and rad53Δ mutations.
Figure 2HU treatment induces association of Pkc1 with Hrr25. (a) Wild-type cells (DL100) co-expressing Pkc1-HA (from p813) and Hrr25-GFP (from p3357) or GFP (from p3358) were treated with 250 mM HU for 4 h. Hrr25-GFP or GFP was immunoprecipitated (IP) from extracts and samples were tested by immunoblot analysis for co-IP of Pkc1-HA. Input Pkc1-HA from extracts is shown at bottom; (b) UV treatment induces association of Pkc1 with Hrr25. Wild-type cells (DL100) co-expressing Pkc1-HA (from p813) and Hrr25-GFP (from p3357) or GFP (from p3358) were treated with UV light (150 J/m2) and returned to culture for 2 h post-irradiation prior to extract preparation. Hrr25-GFP or GFP was immunoprecipitated (IP) from extracts and treated as above; (c) MEC1 and TEL1 are required for the HU-induced association of Hrr25 with Pkc1. Cultures co-expressing Pkc1-HA and Hrr25-GFP (from p3562) were treated with HU as above and processed for co-IP of Pkc1-HA with Hrr25-GFP. Strains were DL3950 (sml1Δ) and DL4277 (sml1Δ tel1Δ mec1Δ). Molecular mass markers (in kDa) are shown on the right.
Figure 3An analog-sensitive form of Hrr25 shows that its catalytic activity is required for the HU-induced Pkc1 band-shift. (a) An hrr25Δ strain complemented by plasmid-borne HRR25 (DL4527) or hrr25-182A (DL4528; encoding an analog-sensitive form) and expressing Pkc1-HA (from p813) was treated simultaneously with HU (250 mM) and/or PP1 analog IV (20 μM) for 4 h. Extracts were processed for immunoblot analysis of Pkc1-HA; (b) A C-terminal truncation of Hrr25 lacking three potential Mec1/Tel1 phosphorylation sites associates normally with Pkc1. An hrr25Δ strain complemented by plasmid-borne HRR25-GFP (DL4541) or hrr25-Δ404 (DL4542) and expressing Pkc1-HA (from p813) was treated with HU (250 mM for 4 h). Hrr25-GFP was immunoprecipitated from extracts and tested for co-IP of Pkc1-HA by immunoblot analysis. Molecular mass markers (in kDa) are on the right; (c) A C-terminal truncation of Hrr25 does not impact the HU-induced Pkc1 band-shift. An hrr25Δ strain complemented by plasmid-borne HRR25 (DL4527) or hrr25-Δ404 (DL4555) and expressing Pkc1-HA was treated with HU as above and processed for immunoblot analysis of Pkc1-HA (d) A mutant form of HRR25 lacking three potential Mec1/Tel1 phosphorylation sites does not impact the HU-induced Pkc1 band-shift. An hrr25Δ strain complemented by plasmid-borne HRR25 (DL4527) or hrr25-3A (DL4556) and expressing Pkc1-HA was treated with HU as above and processed for immunoblot analysis of Pkc1-HA.
Figure 4CK1 phosphorylation sites within the Pkc1 regulatory domain are responsible for the genotoxic stress-induced Pkc1 band-shift. (a) Phosphorylation sites within the Pkc1 regulatory domain mutated in this study. Phosphorylated residues are marked in red. The three residues mutated in the pkc1-3A allele (S2, S577, and S657) are marked by boxes and were identified by SILAC MS as increased in phosphorylation state in response to HU treatment. Two of these residues (S577 and S657) are within consensus CK1 phosphorylation sites, with either a priming phospho-Ser at position −3 (S577) or an acidic residue (Asp) at position −3 (S657). Other phosphorylated residues that reside within CK1 consensus sites are also indicated and were mutated in the pkc1-S/T13A allele. Known regulatory elements, Rho-binding domains (HR1), calcium/lipid-binding domain (C2), and Cys-rich domain (CRD) are also shown. The catalytic domain is C-terminal to the regulatory domain and starts at residue 824; (b) HU-induced phosphorylation band-shift of the Pkc1-3A mutant. Plasmids were PKC1-HA (p813) and pkc1-3A-HA (p3619) (c) The pkc1-3A and pkc1-S/T13A mutants do not show increased sensitivity to genotoxic stress. Serial 10-fold dilutions of cultures grown to mid-log phase in YPD were spotted onto plates (left to right) with or without HU. Cultures treated with UV were similarly diluted and spotted onto YPD plates. Plates were incubated at 25 °C for two days. Plasmids were PKC1-HA (p3623), pkc1-3A (p3624), and pkc1-S/T13A (p3625); (d) HU-induced phosphorylation band-shift of the Pkc1-S/T13A mutant and Rad53. Plasmids were PKC1-HA (p813) pkc1-S/T13A (p3612); (e) UV-induced phosphorylation band-shift of the Pkc1-S/T13A mutant and Rad53. Plasmids were PKC1-HA (p813) and pkc1-S/T13A (p3612). Strain DL1021 (pkc1Δ) was used for experiments shown in (b,d,e). Strain DL376 (pkc1Δ) was used for the experiment in panel (c); (f) HU-induced RNR3-lacZ expression is diminished in a pkc1Δ mutant, and in the pkc1-3A and pkc1-S/T13A mutants. Strain DL376 (pkc1Δ) was co-transformed with pRNR3-lacZ (p2947) and PKC1-HA (p3623), pkc1-3A (p3624), pkc1-S/T13A (p3625), or vector alone (p118). Cells were cultured in the presence of 0.5 M sorbitol for osmotic support (pair on left), or in the absence of sorbitol. Cultures were treated for 4 h with 250 mM HU and β-galactosidase activity was measured from extracts. The hrr25-I82A mutant (DL4528; right) was treated with HU plus or minus PP1 analog IV (20 μM) for 4 h. Each value is the mean and standard deviation from three independent cultures. Pair-wise p-values for HU-treated and untreated samples were calculated using student t-test and were all at least p ≤ 0.00001, except the HU-treated PKC1 and pkc1-3A pair, which was p = 0.0012. An additional p-value of p < 0.00001 was obtained for the hrr25-I82A mutant for HU-treated samples, with and without analog IV.
Figure 5Proposed contribution of Hrr25 and Pkc1 to DNA damage-induced transcription. Pathway from Mec1 and Tel1 through Hrr25 and Pkc1 is added to the pathway established by Huang et al. [26]. Dashed arrows suggest indirect regulation.